Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals is focused on developing therapeutics that meetcritical unmet needs in treating neurodegenerative diseases.
Raised
$43M
Follow us
Alexa global traffic share
24 May 2016
$14,940,000
Venture capital (Series UNDISCLOSED)

SEC FORM D

sec
01 Apr 2012
31 Jan 2012
26 Mar 2009